Patents by Inventor Eric Rowinsky

Eric Rowinsky has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260201061
    Abstract: The present disclosure provides methods for the treatment or prevention of cancers, comprising administration of antigen-binding molecules that bind to HER3 and antigen-binding molecules that bind to EGFR. Also provided are pharmaceutical combinations comprising said molecules, and therapeutic and prophylactic methods of using said pharmaceutical combinations.
    Type: Application
    Filed: December 6, 2023
    Publication date: July 16, 2026
    Inventors: Piers Ingram, Jerome Boyd-kirup, Dipti Thakkar, Eric Rowinsky, Weiyi Toy
  • Publication number: 20250313631
    Abstract: The present disclosure provides antigen-binding molecules that bind to VISTA for the treatment or prevention of cancers, compositions comprising said molecules, and therapeutic and prophylactic methods using said molecules.
    Type: Application
    Filed: September 16, 2022
    Publication date: October 9, 2025
    Applicant: Hummingbird Bioscience Pte. Ltd.
    Inventors: Jerome Boyd-Kirkup, Siyu Guan, Konrad Paszkiewicz, Eric Rowinsky, Dipti Thakkar, Bhushan Dharmadhikari, Piers Ingram
  • Publication number: 20080255132
    Abstract: Methods of treating a human body for cancer are provided. In one aspect, an effective therapeutic amount of paclitaxel is administered in combination with ET-743 in a dose range between 0.5 and 1 mg/m2. In a related aspect, an effective therapeutic amount of ET-743 is administered in combination with paclitaxel in a dose range between 80 and 140 mg/m2.
    Type: Application
    Filed: October 28, 2004
    Publication date: October 16, 2008
    Inventors: Eric Rowinsky, Quincy Siu-Ching Chu, Jose Maria Jimeno Donaque, Luis Lopez Lazaro